Related Experiment Video
Updated: May 29, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Inhibition of xc⁻ transporter-mediated cystine uptake by sulfasalazine analogs
Krupa Shukla1, Ajit G Thomas, Dana V Ferraris
1Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, USA.
Abstract:
A series of sulfasalazine analogs were synthesized and tested for their ability to block cystine-glutamate antiporter system xc⁻ using L-[(14)C]cystine as a substrate. Replacement of sulfasalazine's diazo group with an alkyne group led to an equally potent inhibitor, 2-hydroxy-5-((4-(N-pyridin-2-ylsulfamoyl)phenyl)ethynyl)benzoic acid 6. Our SAR studies also revealed that the carboxylate group of sulfasalazine is essential for its inhibitory activity while the phenolic hydroxyl group is dispensable. Truncated analogs lacking an N-pyridin-2-ylsulfamoyl moiety were less potent than sulfasalazine, but may serve as more tractable templates because of their low molecular weight by applying a variety of fragment growing approaches. Given that sulfasalazine is rapidly metabolized through cleavage of the diazo bond, these analogs may possess a more desirable pharmacological profile as system xc- blockers, in particular, for in vivo studies.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Metabolism: Phase II Reactions
Drug Elimination by Renal Route: Tubular Secretion
Antihypertensive Drugs: Thiazide-Class Diuretics
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
